Dickerman, Barbra A. http://orcid.org/0000-0003-2843-687X
Gerlovin, Hanna http://orcid.org/0000-0002-6700-2129
Madenci, Arin L. http://orcid.org/0000-0003-1258-7278
Figueroa Muñiz, Michael J. http://orcid.org/0000-0001-5747-8767
Wise, Jessica K.
Adhikari, Nimish
Ferolito, Brian R.
Kurgansky, Katherine E.
Gagnon, David R. http://orcid.org/0000-0002-6367-3179
Cho, Kelly
Casas, Juan P.
Hernán, Miguel A. http://orcid.org/0000-0003-1619-8456
Funding for this research was provided by:
U.S. Department of Veterans Affairs (MVP000, MVP000, MVP000)
U.S. Department of Health & Human Services | National Institutes of Health (R00 CA248335)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM140972)
Article History
Received: 28 July 2022
Accepted: 17 October 2022
First Online: 2 January 2023
Competing interests
: B.R.F. reported completing a 6-month paid internship with Moderna before joining the Department of Veterans Affairs and owning five shares of Moderna, Inc. stock purchased in February 2020 outside the submitted work. M.A.H. reported receiving personal fees from Cytel and ProPublica outside the submitted work. The other authors declare no competing interests.
: This work was approved by the VA Boston Healthcare System Research & Development Committee and Human Subjects Subcommittee, and an exemption of informed consent and HIPAA authorization was granted.
Free to read: This content has been made available to all.